Leith Wheeler Investment Counsel’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,230
Closed -$7.34M 71
2025
Q1
$7.34M Buy
21,230
+1,078
+5% +$347K 0.51% 48
2024
Q4
$6.05M Sell
20,152
-11,279
-36% -$3.94M 0.44% 50
2024
Q3
$12.8M Sell
31,431
-8,679
-22% -$3.18M 0.9% 29
2024
Q2
$12.9M Buy
40,110
+7,861
+24% +$2.55M 1.11% 23
2024
Q1
$10.8M Sell
32,249
-1,310
-4% -$400K 1.05% 29
2023
Q4
$9.08M Buy
33,559
+22,650
+208% +$5.6M 0.99% 34
2023
Q3
$2.68M Buy
10,909
+1,390
+15% +$380K 0.35% 49
2023
Q2
$2.89M Sell
9,519
-1,820
-16% -$506K 0.38% 50
2023
Q1
$2.99M Sell
11,339
-1,780
-14% -$452K 0.44% 45
2022
Q4
$3.15M Buy
13,119
+2,790
+27% +$625K 0.47% 44
2022
Q3
$1.9M Buy
10,329
+3,190
+45% +$635K 0.32% 46
2022
Q2
$1.54M Buy
7,139
+5,240
+276% +$1.13M 0.2% 47
2022
Q1
$476K Buy
+1,899
New +$477K 0.07% 48

Other funds holding HCA

Leith Wheeler Investment Counsel's HCA Position: Q2 2025 in Review

Leith Wheeler Investment Counsel sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 21,230 shares — an estimated $7.34M sold.

Leith Wheeler Investment Counsel first reported a position in HCA in Q1 2022 and held it in 13 quarters. The position peaked at $12.9M in Q2 2024. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

  • Leith Wheeler Investment Counsel reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
  • Leith Wheeler Investment Counsel sold 21,230 HCA Healthcare shares in Q2 2025, an estimated $7.34M.
  • Leith Wheeler Investment Counsel first reported a position in HCA Healthcare in Q1 2022 and held it in 13 quarters.
  • Leith Wheeler Investment Counsel's HCA Healthcare position peaked at $12.9M in Q2 2024.
  • 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Leith Wheeler Investment Counsel's 13F filing for Q2 2025, filed 25 Jul 2025.